bims-cliped Biomed News
on Clinical pediatrics
Issue of 2026–10–18
29 papers selected by
Alyssa M. Portwood, Akron’s Children



  1. J Pediatr Pharmacol Ther. 2026 Oct;31(5): 680-688
      Immunization misinformation is rampant, and it is essential that pharmacists remain able to interpret, explain, and recommend evidence-based immunization information to parents and other health care professionals. The Pediatric Pharmacy Association's Immunization Committee strives to provide summaries of important evidence regarding changes to immunizations and clarify confusing or new immunization issues. We intentionally did not include long-standing issues that have already been well addressed elsewhere, either by our committee previously or by other national organizations. In this article, we address the background of immunization approvals, why placebo-controlled trials are not usually optimal, how and why immunization recommendations vary between countries, why it is essential to continue to obtain high rates of immunizations among children, as well as the safety of immunizations containing aluminum and yeast.
    Keywords:  immunization; misinformation; pediatric; pharmacist
    DOI:  https://doi.org/10.5863/JPPT-26-00035
  2. Clin Pediatr (Phila). 2026 Oct 15. 99228261494442
      Despite an ongoing youth mental health crisis, mental health screening practices by pediatric health systems are unknown. The aim of the current study is to describe mental health screening practices in pediatric health systems and identify potential targets for improvement. Pediatric health systems enrolled in a quality improvement study regarding mental health services were surveyed regarding mental health screening practices. Thirty-four of 39 enrolled pediatric health systems from 24 states completed the survey. All systems reported screening for suicide, with most also screening for depression (94%), substance use (94%), and anxiety (88%). Screening was most common for patients over 12 and in primary care and outpatient psychiatry settings. Results highlight areas for improvement in pediatric mental health screening practices and underscore the need for further research.
    Keywords:  health systems; mental health; population health; prevention; screening
    DOI:  https://doi.org/10.1177/00099228261494442
  3. J Public Health Manag Pract. 2026 Oct 13.
       OBJECTIVES: Pediatric hypertension (HTN) requires accurate, timely diagnosis, and management to prevent long-term adverse cardiac events. Our health system's adherence to the American Academy of Pediatrics best practice guidelines (AAP 2017) was noted to be suboptimal, including gaps in blood pressure (BP) screening, repeat BP measurements after an elevated BP, and documentation. A quality improvement (QI) project was conducted to improve adherence to the guideline among children aged 3-18 years at systemwide pediatric primary care clinics from June 2024 through December 2024.
    DESIGN: The QI project was evaluated using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Education on accurate BP measurement and AAP guidelines were delivered in primary care clinics within one Southeast health system. Data were extracted from electronic health records 4 times: preintervention, midpoint, postintervention, and 6-month follow-up.
    RESULTS: Reach: Participating clinics cared for 9781 children, representing 25.27% of the system's population. Effectiveness: Repeat BP measurement after an elevated BP significantly improved from 5.58% preintervention to 11.22% at follow-up, peaking at 17.29% postintervention (P < 0.01). Overall BP screening rates remained stable over time but significantly improved in clinics providing care for both adults and children. The proportion of elevated BP among boys significantly decreased from preintervention to postintervention, whereas no significant changes were observed among girls. Adoption: Approximately three-quarters (73.33%) of invited clinics participated in the QI project. Implementation: Staff education on accurate BP measurements was the most used implementation strategy across participating clinics (100%). Maintenance: BP screening rates remained stable, and repeated BP measurements were partially sustained at 6-month follow-up.
    CONCLUSIONS: This QI project improved adherence to AAP guidelines by increasing accurate BP measurement, primarily through staff education. Further research should explore strategies to improve long-term adherence to pediatric HTN guidelines and address BP measurement challenges in children under the age of 5.
    Keywords:  RE-AIM framework; pediatric hypertension; primary care; quality improvement
    DOI:  https://doi.org/10.1097/PHH.0000000000002500
  4. Sleep Med Rev. 2026 Oct 14. pii: S1087-0792(26)00161-9. [Epub ahead of print]90 102389
      We conducted a systematic review and meta-analysis to estimate the prevalence of children and adolescents meeting sleep duration recommendations across international studies and to examine variation by age group, day type, sex, and region. Three databases were searched. Eligible studies reported adherence to age-specific recommendations (9-11 h/day for children and 8-10 h/day for adolescents). Subjective or proxy-reported estimates were pooled using maximum-likelihood random-effects models of logit-transformed proportions with Knapp-Hartung confidence intervals. Fifty-three studies including 1,402,868 participants (49.7% female) were included. Pooled prevalence was 76.5% (95% CI 71.6-80.9) in children and 54.8% (95% CI 50.0-59.6) in adolescents. Adolescents had lower odds of meeting recommendations before multiplicity adjustment (OR = 0.37, 95% CI 0.15-0.94; p = 0.040), but not after Holm adjustment (p = 0.120). Prevalence was lower on school than non-school days in children (56.7% vs 82.2%; based on three publications) and adolescents (50.6% vs 86.4%; both Holm-adjusted p < 0.001). No robust sex differences were observed. Regional estimates varied substantially and require cautious interpretation because of extreme heterogeneity and uneven geographic representation. In conclusion, insufficient sleep appears especially common during adolescence and on school days, supporting strategies to improve sleep during the school week. PROSPERO REGISTRATION NUMBER: CRD420261289109.
    Keywords:  Health behavior; Insufficient sleep; Non-school days; Public health surveillance; School days; School-aged youth
    DOI:  https://doi.org/10.1016/j.smrv.2026.102389
  5. Pediatrics. 2026 Oct 16. pii: e2026076714. [Epub ahead of print]
       BACKGROUND/OBJECTIVES: Many professional organizations recently recommended inpatient screening for social risks. Although prior studies have explored social risk screening rates in children's hospitals, many excluded community hospitals and lacked detail on screening practices. We aimed to describe national social risk screening and referral practices among hospitals caring for children.
    METHODS: We conducted a cross-sectional survey (August 2023-November 2023) through the Pediatric Research in Inpatient Settings Network. One clinical leader per institution was surveyed on inpatient social risk screening and referral processes, populations, tools and data tracking, and barriers/facilitators to social care. Descriptive statistics summarized survey responses.
    RESULTS: Of the hospitals contacted, 80.2% (77/96) completed the survey. Overall, 66.7% of hospitals reported screening for social risks in some capacity, most commonly performed by nurses. Screening tools and domains varied widely, with 21.9% using a published tool and 12.5% using internally developed questions. Food insecurity was the most frequently screened domain (91.9%), whereas screening for legal needs was least common (0%). Most hospitals had systems to refer patients to in-hospital (98.4%) and out-of-hospital (96.8%) services, primarily through social work consultations (96.5%) and printed handouts (54.4%). Fewer than 10% partnered with community-based organizations. Less than 45% of screening hospitals had a data-tracking system for referrals, and only 2.5% collected patient health care use data. Staffing was the most cited barrier to screening.
    CONCLUSIONS: Social risk screening and referral practices vary widely among hospitals caring for children. Standardized policies and support mechanisms may reduce variability and promote equitable social care practices across hospitals.
    DOI:  https://doi.org/10.1542/peds.2026-076714
  6. J Pediatr Urol. 2026 Sep 24. pii: S1477-5131(26)00581-4. [Epub ahead of print]23(1): 106302
       INTRODUCTION: Primary nocturnal enuresis (PNE) is a prevalent disorder among children and adolescents that can lead to significant physiological and psychological consequences if left untreated. Our study aimed to evaluate current practices in PNE management by surveying pediatricians to understand contemporary approaches and identify areas needing improvement.
    METHODS: An anonymous survey comprising 24 questions was distributed electronically to pediatricians affiliated with the Georgia Chapter of the American Academy of Pediatrics and practicing pediatricians in Argentina, Spain, and Brazil. Questions were focused on current practices, treatment preferences, perceived effectiveness, and the specific obstacles faced in managing PNE in children. Interventional therapies are defined as medical treatments (bedwetting alarms/devices). Non-interventional therapies were defined as behavioral modifications (fluid restriction, timed voiding, bladder training) and supportive therapy (positive reinforcement, reassurance).
    RESULTS: A total of 234 pediatricians participated across four countries. Non-interventional therapies predominated as first-line management for children aged 5-7 years in all regions. Significant variation emerged in older age groups, with interventional therapies more commonly used in the United States and Spain, while referral to specialists was more frequent in Argentina and Brazil (p < 0.001). 43.1% of pediatricians reported delaying treatment initiation due to concerns regarding the limited effectiveness of current therapies.
    CONCLUSION: The current dissatisfaction with available treatments underscores the necessity for improved therapeutic approaches. Further research is needed to determine the factors contributing to variation in PNE management across countries.
    Keywords:  Bedwetting; Clinical decision-making; Multinational survey; Pediatric urology; Practice patterns; Primary nocturnal enuresis
    DOI:  https://doi.org/10.1016/j.jpurol.2026.106302
  7. Cureus. 2026 Sep;18(9): e116168
      Early recognition of pediatric sepsis remains challenging because clinical presentation, sepsis definitions, and recognition approaches vary across healthcare settings. This systematic review evaluated clinical and digital strategies for the early recognition of pediatric sepsis, including structured screening tools, electronic alerts, prediction models, machine-learning approaches, clinical decision support, and recognition pathways. Diagnostic criteria were considered separately as reference frameworks for classifying established sepsis and interpreting the performance of recognition tools. PubMed and Scopus were systematically searched, eligible studies were independently screened, data were extracted, and methodological quality and risk of bias were assessed using design-appropriate tools. Because of substantial clinical and methodological heterogeneity, the evidence was synthesized narratively. A total of 13 studies were included. Several clinical and digital approaches generally performed well in ruling out sepsis among low-risk children; however, their ability to identify true cases and limit unnecessary alerts varied according to alert thresholds, clinical settings, and the sepsis definition or reference standard used. No single approach was consistently superior for early recognition. Automated screening appeared most useful when integrated with structured clinical assessment rather than used independently. Differences in pediatric sepsis definitions substantially influenced reported performance, and implementation studies more consistently demonstrated improvements in recognition and care processes than in patient outcomes. The available evidence was limited by heterogeneous methods, imperfect reference standards, insufficient external validation, and risk of bias. Clinical and digital recognition systems may support earlier identification of children with suspected infection who require further assessment; however, current evidence does not establish a universally superior approach. Further prospective multicenter studies are needed to determine which strategies provide meaningful clinical benefit across diverse healthcare settings.
    Keywords:  clinical decision support; early diagnosis; machine learning; pediatric sepsis; sepsis screening
    DOI:  https://doi.org/10.7759/cureus.116168
  8. Pediatr Emerg Care. 2026 Oct 14.
       OBJECTIVES: Over 80% of pediatric emergency department (ED) visits in the United States occur outside of children's hospitals. Although previous studies have described gaps in pediatric readiness, few studies have focused on pediatric disaster preparedness at rural and critical access hospitals (CAHs). During periods of pediatric surge, CAHs may be forced to manage pediatric patients with delayed transfer times. This mixed-methods study, conducted by the Region V for Kids (RV4K) Pediatric Disaster Center of Excellence, elicited strengths and barriers to pediatric disaster preparedness in rural and CAHs.
    METHODS: We conducted a qualitative study of clinicians from CAHs in the Health Resources and Services Administration (HRSA) Region 5. After completing a demographic survey, respondents were invited to participate in focus groups about pediatric disaster preparedness, followed by an open-response questionnaire about how RV4K can support rural and CAHs. Descriptive statistics were calculated. Focus group transcripts and questionnaire responses were analyzed using a constant comparative approach to identify themes.
    RESULTS: Of the 41 survey respondents, 19 participated in focus groups. Most study participants worked at EDs seeing <1800 children per year, and less than half had pediatric inpatient capabilities. Few hospital disaster plans considered children. Four focus group themes emerged: strengths of staff and community, staffing limitations, and desire for targeted pediatric education resources and pediatric disaster plan development.
    CONCLUSIONS: Our study engaged directly with staff at rural and CAHs to gain insights about pediatric preparedness that will be used to develop resources specifically tailored to CAHs' unique clinical needs.
    Keywords:  critical access hospitals; disaster preparedness; pediatric disaster preparedness; pediatric readiness; rural hospitals; tripledemic
    DOI:  https://doi.org/10.1097/PEC.0000000000003727
  9. Pediatrics. 2026 Oct 13. pii: e2026076351. [Epub ahead of print]
       OBJECTIVE: Updates to national and international guidelines now recommend shortening antibiotic durations to 3 to 5 days for uncomplicated community-acquired pneumonia (CAP) and 5 to 7 days for acute bacterial rhinosinusitis (ABRS). We aimed to increase the percentage of children discharged home from the emergency department with CAP or ABRS who were treated with an optimal antibiotic duration from 13% to 70% by July 2025.
    METHODS: We assembled a multidisciplinary team and used quality improvement tools, including cause-and-effect analysis, driver diagram, and prioritization matrix, to identify impactful interventions. We also surveyed prescriber comfort with shorter antibiotic durations. Plan-Do-Study-Act cycles included implementing new clinical pathways (CP), electronic health record (EHR) updates, and educating prescribers. Our outcome metric was the percentage of patients receiving recommended antibiotic duration for CAP and ABRS. Process metrics included use of CP Quick Response codes and CAP "Quick-Discharge" order sets. Balancing metric was the number of return visits with the same diagnosis within 14 days.
    RESULTS: We saw shifts in the outcome metric center line in August 2023, February 2024, and November 2024 from 13.1% to 64.8%. These changes primarily reflected CAP duration because it was the more common diagnosis, although ABRS short antibiotic durations showed similar improvement during this time frame. Process metrics showed an increase over time. There was no change in balancing metric.
    CONCLUSION: We significantly improved antibiotic prescription durations for CAP and ABRS through CP changes, EHR updates, prescriber education and feedback, and resource distribution.
    DOI:  https://doi.org/10.1542/peds.2026-076351
  10. Pediatrics. 2026 Oct 15. pii: e2026077711. [Epub ahead of print]
      
    OBJECTIVES: Medical advances have allowed more children with medical complexity (CMC) to live at home, but previous research has linked implanted tubes to patient safety events. We aimed to characterize challenges and strategies parents use to deliver their children's tube-related care at home and how parents communicate about their experiences to identify system-level intervention opportunities.
    METHODS: We conducted a qualitative study using virtual contextual inquiry to asynchronously observe parents through self-submitted photos, text-based messages, or audio recordings with a national sample of English- and Spanish-speaking parents of CMC. Over 1 week, parents responded to twice-daily surveys soliciting messages about their child's tube-related care. Parents were subsequently interviewed to discuss messages. Content analysis characterized parent challenges and strategies employed for safety.
    RESULTS: We enrolled 21 parents from individual families, received 267 total messages, and completed 18 interviews. Overall, 13% (n = 36) of messages were challenges; 57% (n = 151) depicted strategies to care for CMC at home; and 26% (n = 70) were both. Challenges included supply issues (24%, n = 25), devices not working as intended (22%, n = 23), and irregularities in care experienced as normal (20%, n = 21). Strategies were personalized and creative and included supporting CMC's activities of daily living (63%, n = 139), organization techniques (42%, n = 93), and tube-related preparation (40%, n = 89). Parents often did not share challenges and strategies with their child's care team.
    CONCLUSIONS: Parents of CMC navigate patient safety challenges during daily tube-related care and create strategies to mitigate safety risks. Challenges at home demand multipronged systemic intervention; findings highlight creative, independent, and resourceful parent-developed strategies.
    DOI:  https://doi.org/10.1542/peds.2026-077711
  11. J Pediatr Pharmacol Ther. 2026 Oct;31(5): 689-704
      The significant rise in rates of depression and anxiety in children and adolescents coupled with underdiagnosis and undertreatment poses a serious health threat to the pediatric population. The escalating pediatric mental health crisis has been associated with rising suicide rates and attempts, increased deaths due to drug overdose, higher health care costs, and limited access to adequate care. A shortage of mental health resources and specialized providers in both community and institutional settings further exacerbates these challenges. This paucity of care highlights the need for additional support, and pharmacists, as accessible health professionals, can help bridge the gap in pediatric mental health care. Pharmacists play a vital role in pediatric mental health by advocating for and performing mental health screenings for pediatric patients presenting with acute psychological and behavioral health issues across various care settings, including emergency departments, inpatient units and outpatient pharmacies. Additionally, pharmacists enhance the efficacy and safety of psychotropic therapies in children with diagnosed mental health conditions by minimizing drug interactions, optimizing dosing, monitoring for adverse effects, and providing patient and family education. This article serves as a Position Statement of the Pediatric Pharmacy Association (PPA), which strongly advocates for the inclusion of pharmacists as key members of multidisciplinary teams supporting pediatric patients with mental health challenges, emphasizing their critical role in improving patient outcomes. Additionally, PPA advocates for routine mental health screenings for all pediatric patients and recommends utilization of referrals and standardized workflows for managing pediatric mental health conditions and substance use disorders.
    Keywords:  continuity of patient care; emergency medical services; mental health; patient advocacy; pediatrics; pharmacists; psychology
    DOI:  https://doi.org/10.5863/JPPT-25-00102
  12. Endocr Pract. 2026 Oct 16. pii: S1530-891X(26)01285-1. [Epub ahead of print]
       OBJECTIVE: Type 1 diabetes (T1D) follows a trajectory defined by four stages. Autoantibody screening and disease-modifying therapy (DMT) strategies to preserve beta-cell function are rapidly emerging. Clinical implementation guidance is limited.
    METHODS: A national group of pediatric and adult endocrinology experts was formed through invitation by a nonprofit network of over 60 centers. Experts were invited based on their expertise in autoantibody (AAB) screening for T1D and treating children and adults at risk for T1D. The group comprised 22 experts from 13 academic medical centers across the U.S. Group meetings were held from November 2025 to February 2026 to agree on topics for inclusion, form writing groups, and develop evidence-based statements using a targeted literature search.
    RESULTS: Topics covered include current guidelines, AAB screening framework, early stage and stage 3 T1D, clinical protocol for T1D screening, treatment and Quality Improvement framework, education, social and behavioral considerations, and the implementation gap. Early identification of T1D through screening allows additional time for families to receive comprehensive diabetes education and appropriate psychological support. This provides a smoother transition to stage 3 disease while reducing hospitalizations, length of stay, and allowing consideration of DMT in early stage or stage 3 T1D. Guidance on real-world clinical implementation of T1D AAB screening and DMT remains limited.
    CONCLUSION: This article provides a national consensus from T1DX-QI on the clinical implementation of T1D AAB screening in those at risk and DMT for beta-cell preservation for individuals in stage 2 and new onset stage 3 T1D.
    Keywords:  consensus; prevention; screening; teplizumab; type 1 diabetes
    DOI:  https://doi.org/10.1016/j.eprac.2026.10.003
  13. Front Pediatr. 2026 ;14 1932363
       Background: Adults with Down syndrome (DS) increasingly require structured transition from pediatric to adult healthcare, yet disease-specific guidance remains limited.
    Methods: We reviewed current evidence and combined it with the multidisciplinary clinical experience of the Belgian National Scientific Board for Down Syndrome to identify barriers and propose practical recommendations.
    Results: Transition in DS is challenged by intellectual disability, multimorbidity, fragmented adult care, structural healthcare inequalities, delayed primary care involvement, parental ageing, and poor coordination between medical and social services. We propose a person-centered framework emphasizing early preparation, supported decision-making, multidisciplinary collaboration, early engagement of general practitioners, accessible communication, and integrated medico-social support.
    Conclusions: Disease-specific transition pathways are needed to improve continuity of care, promote autonomy, and reduce health inequalities. Prospective studies should evaluate transition models and include the perspectives of people with DS and their families.
    Keywords:  adolescent health; continuity of care; down syndrome; healthcare transition; intellectual disability; multidisciplinary care; primary care
    DOI:  https://doi.org/10.3389/fped.2026.1932363
  14. Hosp Pediatr. 2026 Oct 12. pii: e2026009495. [Epub ahead of print]
       OBJECTIVE: To assess pediatric hospital medicine (PHM) division leaders' perspectives on gender equity in their divisions and organizations.
    METHODS: In 2025, we conducted a cross-sectional Research Electronic Data Capture survey distributed via email to 236 PHM division leaders. The survey consisted of 53 items on division and leader demographics, promotion, leadership, benefits, and gender-related experiences. Descriptive statistics summarized numeric responses, and qualitative content analysis identified emerging themes in free-text responses.
    RESULTS: Responses from 125 PHM division leaders (53% response rate) were received. Leaders were predominately women (69%) and held PHM subboard certification (84%), with a median of 15 years of practice as a hospitalist. According to leaders, 76% of their faculty were women. No gender differences were reported in faculty rank or leadership roles. Compensation analysis by gender was reported by only 26% of responding institutions. Similarly, although wellness support was common, gender-stratified analyses of outcomes were rarely performed (19%). Mean paid parental leave offered to birth parents was 8 weeks. Qualitative analysis of leaders' suggestions to drive change toward gender equity revealed 6 major themes: (1) compensation transparency, (2) caregiver support, (3) career development, (4) countering gender bias through education and allyship, (5) fostering psychological safety, and (6) advancing institutional accountability.
    CONCLUSIONS: Division leaders reported gaps in gender equity practices alongside systemic challenges in PHM. Identified priorities include transparent compensation practices, caregiver-inclusive benefits, career pathways, and leadership accountability. As the first national assessment of PHM leaders' perceptions, these findings highlight opportunities to strengthen structural support for gender-equitable advancement for all clinicians.
    DOI:  https://doi.org/10.1542/hpeds.2026-009495
  15. Curr Pain Headache Rep. 2026 Oct 14. pii: 131. [Epub ahead of print]30(1):
       PURPOSE OF REVIEW: This is a narrative review to summarize current evidence on use of therapies targeting calcitonin gene-related peptide (CGRP) for children and adolescents with headache disorders.
    RECENT FINDINGS: The CGRP-targeting therapies have been used in adults for prevention of migraine since 2018. There is one randomized controlled trial (RCT) published on fremanezumab in children age 6-17 years old which showed favorable outcome as a preventive treatment for episodic migraine. Several real-world evidence (RWE) studies report on use of CGRP-targeting therapies in patients younger than 18 years old. Several clinical trials are pending for other CGRP-targeting therapies.
    CONCLUSION: There is a small number of RWE studies and one RCT study that shows that CGRP-targeting therapies have potential to be beneficial and safe to use in children and adolescents with headache disorders. Future clinical trials, once completed, will further shed light on efficacy and safety of CGRP-targeting therapies.
    Keywords:  Adolescent; Calcitonin-gene-related peptide (CGRP); Headache; Migraine; Pediatric
    DOI:  https://doi.org/10.1007/s11916-026-01567-4
  16. Med J Islam Repub Iran. 2026 ;40 61
       Background: Emergency departments with high readiness to admit children may reduce mortality rates, but comprehensive and comparative evidence is limited. This study is the first systematic review and meta-analysis conducted to determine the effect of pediatric emergency department readiness on in-hospital mortality.
    Methods: A search for relevant articles was conducted up to 17 December 2025 in the international databases PubMed, EMBASE, Scopus, and Web of Science. Relevant keywords were used for the search. Current study question: In children presenting to emergency departments (Population), how is the level of emergency readiness for pediatric care (Exposure) associated with mortality (Outcome)? This section was created using the PICO approach. Data analyses were conducted using the meta-analysis packages in STATA/MP.v17 (College Station, Texas, USA).
    Results: The overall in-hospital mortality rate was estimated to be about 2%. Meta-analysis showed that care at highest-readiness EDs (Quartile 4 wPRS) was associated with a significant reduction in mortality (OR=0.617; 95% CI, 0.491-0.744).
    Conclusion: Increasing the level of emergency department pediatric readiness can be associated with a reduction in in-hospital mortality. These findings highlight the importance of policy to improve standards of pediatric emergency readiness in all hospitals.
    Keywords:  Children; Pediatric Emergency Department; Readiness; in-hospital mortality
    DOI:  https://doi.org/10.47176/mjiri.40.61
  17. J Perinatol. 2026 Oct 12.
       OBJECTIVE: Timely interventions during the "Golden Hour" (GH) reduce neonatal morbidity and mortality. We aimed to decrease hypothermia, time to antibiotics and intravenous fluids (IVF) initiation and invasive ventilation by 25%, bronchopulmonary dysplasia (BPD) by 10% and achieve 50% adherence to a GH bundle in our NICU.
    STUDY DESIGN: We conducted a quality improvement initiative using seven Plan-Do-Study-Act cycles (December 2021-October 2023) for infants <32 weeks gestation and/or ≤ 1500 grams. Outcomes were analyzed using statistical process control charts.
    RESULTS: Over the study period, moderate-severe hypothermia decreased from 25% to 0%, the mean time to antibiotics improved from 132 to 77 min and IVF initiation within GH increased from 30% to 86%. Grade 2/3 BPD decreased from 37% to 19%. GH bundle adherence reached 88%.
    CONCLUSION: Implementation of a structured golden hour bundle, incorporating standardized admission workflows, improved thermoregulation practices, and optimized early respiratory management, resulted in improved outcomes in at-risk preterm infants.
    DOI:  https://doi.org/10.1038/s41372-026-02925-1
  18. J Surg Res. 2026 Sep 22. pii: S0022-4804(26)00589-5. [Epub ahead of print]328 85-93
       INTRODUCTION: Delays in surgical management of pediatric gallstone disease remain common. This quality improvement initiative evaluated contributors to delayed surgical management and implemented a standardized care protocol to improve hospital length of stay (LOS), time to cholecystectomy (TTC), and imaging utilization.
    METHODS: We conducted a two-phase quality improvement initiative at two pediatric hospitals within the same health system. Phase 1 was a retrospective cohort study of children ≤18 y old who underwent semiurgent cholecystectomy during admission for symptomatic cholelithiasis. Associations between hospital LOS and TTC and patient, clinical, and system-level factors were analyzed using multivariable logistic regression. Phase 1 findings informed a standardized algorithm, emphasizing early surgical consultation and risk stratification for choledocholithiasis. Phase 2 compared LOS, TTC, and preoperative magnetic resonance cholangiopancreatography (MRCP) utilization before and after implementation.
    RESULTS: Among 187 preimplementation patients, 45% presented to the emergency department (ED) and 55% were transferred. Surgical consultation at presentation occurred in 74% of ED and 27% of transfers. Multivariable analysis demonstrated lower odds of LOS >2 d (odds ratio: 0.29, 95% confidence interval: 0.13-0.66) and TTC >2 d (odds ratio: 0.31, 95% confidence interval: 0.14-0.69) with early surgical consultation, independent of diagnosis, and point of entry. Following protocol implementation, median LOS decreased from 3 to 2 d and median TTC from 2 to 1 d (P < 0.001). MRCP utilization decreased from 39% to 24% (P = 0.013).
    CONCLUSIONS: Implementation of a standardized, surgery-directed care pathway was associated with reduction in LOS, TTC, and MRCP utilization, supporting broader implementation and further refinement of pediatric choledocholithiasis risk stratification strategies.
    Keywords:  Cholecystectomy; Clinical care pathway; Pediatric cholelithiasis; Quality improvement
    DOI:  https://doi.org/10.1016/j.jss.2026.09.006
  19. Curr Opin Pediatr. 2026 Oct 16.
       PURPOSE OF REVIEW: Recent advances in the power, utility, and accessibility of artificial intelligence (AI) have enabled new methods of investigation in the biomedical sciences and opportunities to transform clinical workflows. As allergic conditions are among the most common chronic diseases affecting children, pediatric allergy represents a promising area for AI-augmented informatics methods to support molecular discovery, early identification, risk stratification, treatment customization, and longitudinal monitoring, as reviewed herein.
    RECENT FINDINGS: Recent pediatric allergy studies have applied informatics and AI methodologies across various data sources, including molecular and multiomic data, structured and unstructured electronic health record data, environmental exposures, diagnostic images, remote monitoring devices, and patient- and clinician-facing AI tools. Primarily still in the research phase, these approaches include biomarker discovery, disease phenotyping, risk stratification, prediction modeling, remote monitoring, and emerging chatbots for allergy education.
    SUMMARY: Although still relatively nascent within pediatric allergy, AI-augmented informatics shows promise for extracting usable information from complex data and developing tools aimed at personalizing disease detection and management. Most applications remain investigational, and continued progress will require transparency, rigorous validation, generalizability across diverse populations and health systems, feasibility of workflow integration, privacy protection, and longitudinal oversight to ensure continued safety and effectiveness.
    Keywords:  artificial intelligence; biomedical informatics; clinical informatics; machine learning; pediatric allergy
    DOI:  https://doi.org/10.1097/MOP.0000000000001623
  20. Nutrients. 2026 Oct 08. pii: 3298. [Epub ahead of print]18(19):
      Specialized nutrition products are often used as a component of nutrition care across a spectrum of acute and chronic pediatric medical conditions. These products differ from conventional foods due to their clinical purpose, composition, and context of use, yet these distinguishing characteristics are rarely discussed collectively. The objective of this narrative review is to provide an interdisciplinary overview of specialized pediatric nutrition products, including their clinical applications, formulation considerations, regulatory environment, and future opportunities for innovation and evidence generation. These products are specially formulated and processed to provide nutrition support for vulnerable children during critical periods of growth and development. At the same time, they are subject to specialized and complex regulations. Globally, there is increased interest in the role of food formulation and processing in childhood nutrition. As policy landscapes evolve, attention should be given to specialized pediatric nutrition products to ensure continued availability and support for future research and innovations that benefit pediatric growth, development, and health outcomes.
    Keywords:  FSDU; FSMP; enteral nutrition; medical foods; medical nutrition therapy; oral nutrition supplements; pediatric malnutrition; pediatric nutrition; specialized nutrition products
    DOI:  https://doi.org/10.3390/nu18193298
  21. Child Maltreat. 2026 Oct 16. 10775595261497652
      Child abuse and maltreatment remain major public health concerns in the United States. Early identification is challenging, particularly for clinicians without specialized pediatric training, and disparities in detection raise concerns about bias. Universal screening integrated into electronic health records (EHRs) may improve detection and equity. To develop an evidence-based, user-friendly, and broadly applicable universal child abuse screening tool (U-CAST) for integration into the EPIC Foundation System. A qualitative study engaged nine expert working groups comprising 17 specialists in child abuse pediatrics, pediatric trauma surgery, general pediatrics, and pediatric emergency medicine. Between February and April 2022, groups met virtually to discuss screening content, clinical decision support, workflow integration, and implementation considerations. Meeting transcripts were analyzed using inductive coding and thematic analysis. Five themes emerged: (1) the importance of universal screening; (2) essential tool components; (3) appropriate clinical settings; (4) actionable follow-up protocols for positive screens; and (5) local program evaluation. Preliminary implementation data demonstrated successful integration, high screening completion rates, and encouraging performance in identifying children with suspected physical abuse. U-CAST was developed through a multi-disciplinary expert process and designed for integration into Epic workflows. Preliminary findings support its feasibility and clinical utility.
    Keywords:  child abuse; pediatrics; universal screening tool
    DOI:  https://doi.org/10.1177/10775595261497652
  22. Paediatr Drugs. 2026 Oct 13.
       BACKGROUND: Ibuprofen and acetaminophen are the most widely used antipyretic agents in pediatric practice. Despite their common use, comparative evidence on their relative efficacy in febrile children remains heterogeneous, and clinical recommendations vary across guidelines and countries.
    OBJECTIVE: We aimed to evaluate the comparative antipyretic efficacy of ibuprofen versus acetaminophen in febrile children through a systematic review and meta-analysis restricted to randomized controlled trials.
    METHODS: A systematic search was conducted in Scopus, PubMed, and Web of Science using a predefined strategy combining terms for ibuprofen, paracetamol/acetaminophen, fever/febrile/pyrexia, and pediatric populations. The primary outcome was the proportion of children afebrile at 4 h. Continuous outcomes included temperature reduction at 4 h, time without fever during the first 4 h, and time-weighted summary temperature differences over 0-8 h. The study protocol was registered in PROSPERO (CRD420261353471).
    RESULTS: A total of 479 records were identified; after duplicate removal and screening, seven studies were included in the quantitative synthesis. For the primary outcome of afebrile status at 4 h, the pooled risk ratio was 1.26 (95% confidence interval [CI] 0.88-1.80; p = 0.106). Temperature reduction at 4 h was significantly greater with ibuprofen (mean difference 0.31 °C, p = 0.024). The time-weighted summary temperature outcome over 0-8 h numerically favored ibuprofen but did not reach statistical significance (mean difference - 3.52, 95% CI - 21.24 to 14.21; p = 0.240; I2 = 57.6%). An exploratory standardized mean difference analysis across heterogeneous continuous outcomes (seven comparisons) yielded a near-null pooled effect (Hedges' g - 0.08, 95% CI - 0.40 to 0.25; p = 0.645; I2 = 84.0%).
    CONCLUSIONS: The primary outcome-the proportion of children achieving afebrile status at 4 h-did not differ significantly between ibuprofen and acetaminophen (risk ratio 1.26, 95% CI 0.88-1.80; p = 0.106). Ibuprofen produced a statistically greater reduction in temperature at 4 h compared with acetaminophen (mean difference 0.31 °C), although this difference is unlikely to be clinically meaningful. These findings suggest a marginal quantitative advantage of ibuprofen to decrease body temperature, without a clinically significant difference between the two agents.
    DOI:  https://doi.org/10.1007/s40272-026-00773-2
  23. Pediatr Emerg Care. 2026 Oct 12.
       BACKGROUND: Pediatric emergency department (ED) headache presentations may follow heterogeneous clinical courses.
    OBJECTIVE: To compare presentation characteristics, migraine order-set activation, pain-score change, treatment intensity, and health care utilization between pediatric ED headache encounters with and without a clinician-documented persistent/intractable headache.
    METHODS: We conducted a multisite retrospective cross-sectional study of children aged 3 to 18 years presenting to 2 pediatric EDs with headache or migraine as a chief complaint from 2019 to 2023. Encounters were classified by clinician documentation of an intractable/refractory headache diagnosis or persistent symptoms despite initial treatment. The primary outcome was change from arrival to posttreatment/disposition pain score. Sensitivity analyses were restricted to each patient's first encounter and to clinician-documented migraine or status migrainosus.
    RESULTS: Among 529 encounters, 18.5% had a documented persistent/intractable headache course. Most presentation characteristics were similar, although symptom duration and pulmonary comorbidity differed. Order-set activation did not differ significantly (76.5% vs. 68.2%; P = 0.106). Encounters with a persistent/intractable headache had less pain improvement [median: -4 (interquartile range: -6.75 to -1) vs. -5 (interquartile range: -7 to -3); P = 0.002], received more medications, radiologic imaging (39.8% vs. 26%; P = 0.006), neurology consultation (56.1% vs. 39.4%; P = 0.003), hospitalization (19.4% vs. 3.2%; P < 0.001), and 30-day return ED visits (10.2% vs. 4.6%; P = 0.049). The pain-score difference was attenuated in the first-encounter analysis (P = 0.060), but persisted in the clinician-documented migraine subgroup (P = 0.006).
    CONCLUSION: Headache presentation characteristics and order-set activation did not distinguish the ED course, but pain improvement, treatment intensity, and utilization differed during ED care. Prospective studies should evaluate standardized early reassessment measures.
    Keywords:  headache; intractable; migraine; pain score; pathway; pediatric emergency department
    DOI:  https://doi.org/10.1097/PEC.0000000000003732
  24. J Knee Surg. 2026 Oct 16.
       BACKGROUND: Multi-ligamentous knee injuries (MLKI) in pediatric patients generally occur due to high-energy mechanisms, exhibiting unique injury patterns when compared to adults. Further understanding of the injury patterns, functional outcomes, and post-surgical complications in pediatric patients sustaining MLKI is warranted.
    HYPOTHESIS/PURPOSE: To systematically review the literature to evaluate causes and outcomes of MLKIs in pediatric patients.
    STUDY DESIGN: Level IV Methods: Studies published in PubMed, Embase, and the Cochrane Library reporting on MLKIs in the pediatric population from inception to January 2026 were identified. Inclusion criteria included studies written in English reporting on pediatric patients (≤18 years) undergoing management of MLKIs, with reported lesion etiology, surgical technique, postoperative complications, reoperations, and any patient-reported outcomes (PROs).
    RESULTS: Four studies comprising 142 patients with a weighted mean follow-up of 41.2 months (range 9.5-204) were identified. The weighted mean patient age and BMI were 16.2 years (range 6-18) and 24.9 kg/m2 (range 17.9-41.6), respectively, with 69.7% (n=99/142) of patients being male. The most common injury mechanism was sports-related (70.6%, n=96/136). The posterolateral corner (PLC) was the most commonly injured structure in 71.1% (n=101/142) of patients, followed by injuries to the posterior cruciate ligament (PCL; 66.2%, n=94/142) and anterior cruciate ligament (ACL; 57.7%, n=82/142). Surgical reconstruction was performed in 96.0% (n=97/101) of PLC-involved injuries, 98.9% (n=93/94) of PCL injuries, 98.8% (n=81/82) of ACL injuries, and 48.4% (n=15/31) of MCL injuries. Repair was performed in 4.0% (n=4/101) of PLC injuries, 1.1% of PCL injuries (n=1/94), 1.2% (n=1/82) of ACL injuries, and 38.7% (n=12/31) of MCL injuries. Complications were reported in 36% (n=19/53) of patients, most commonly stiffness (11.3%, n=6/53) and reconstruction failure (5.7%, n=3/53). Revision procedures were reported in 7.5% (n=4/53) of patients.
    CONCLUSION: MLKIs in pediatric patients are most commonly reported following sport-related mechanisms, with the PLC and PCL most frequently involved. Surgical reconstruction is more frequently reported when compared to repair procedures, with complications and revision surgery reported in 36% and 7.5% patients, respectively.
    DOI:  https://doi.org/10.1055/a-2982-7395
  25. Pediatr Transplant. 2026 Oct;30(10): e70492
       BACKGROUND: Black children in the US with ESKD experience higher mortality, lower transplant rates, and longer time on dialysis than other children. Prior research on health disparities in adult kidney patients often emphasizes patient-level psychosocial factors, yet little is known about how providers understand these inequities for children. This study explored pediatric dialysis and transplant social workers' explanations for racial disparities affecting US black children in kidney transplant access.
    METHODS: Semi-structured interviews were conducted with 16 pediatric dialysis and transplant social workers from across the US. Participants were recruited through professional listservs and direct outreach to pediatric nephrology programs. Interview transcripts were analyzed using thematic analysis informed by ecological systems theory.
    RESULTS: Four primary themes emerged: lack of resources, family composition, distrust, and systemic racism. The barriers to transplant that black children face are not limited to the patient-level microsystem as previously described in the literature but rather persist across all ecological system layers. Social workers identified microsystem level barriers as having mesosystem level impact when provider bias leads to judgment about transplant readiness. Social workers named systemic racism as a barrier that transcends all levels of the ecological system, from microaggressions to provider bias to race "corrections" in clinical algorithms to white supremacy to the legacy of slavery.
    CONCLUSIONS: Findings suggest that transplant evaluation processes may reinforce structural racism. Unlike prior studies emphasizing patient-level explanations, participants identified healthcare systems as key contributors to inequity. Further research should seek the voices of black patients and identify interventions to improve equity.
    Keywords:  health equity; kidney transplant; pediatric; social work; systemic racism
    DOI:  https://doi.org/10.1111/petr.70492
  26. J Pain Symptom Manage. 2026 Oct 14. pii: S0885-3924(26)01026-2. [Epub ahead of print]
       BACKGROUND: Pain management in pediatric palliative care is challenging, particularly in children with neurological impairments, feeding difficulties, or low opioid requirements. Transdermal buprenorphine offers pharmacological advantages, including stable plasma concentrations and a reduced risk of sedation; however, its use in children remains off-label and insufficiently studied.
    AIM: To evaluate the use, effectiveness, and safety of transdermal buprenorphine in pediatric palliative care and assess its feasibility in everyday clinical practice.
    DESIGN: Retrospective observational study. Data were extracted from structured electronic medical records, including patient characteristics, analgesic indications, buprenorphine dosing and titration, clinical outcomes, and adverse effects.
    SETTING/PARTICIPANTS: The study included 23 pediatric patients aged 8 months to 17 years treated between April 2023 and April 2025. Participants received care either from a specialized outpatient pediatric palliative care service (SOPPC; German: Spezialisierte Ambulante Palliativversorgung für Kinder und Jugendliche, SAPV-KJ; 74%) or an inpatient pediatric palliative care unit. All patients received transdermal buprenorphine for chronic pain. Those treated with other forms of buprenorphine or alternative opioids were excluded.
    RESULTS: All patients initiated treatment with a 5 µg/h patch; 43% required dose escalation. Pain control was rated as good in 87% (95% CI: 66-96%). Improved alertness was observed in 74% (95% CI: 52-88%). Mild local skin reactions occurred in 13%, and no serious adverse events were reported. Sublingual buprenorphine was used effectively for breakthrough pain in 26% of cases. Four patients were managed with transdermal buprenorphine monotherapy.
    CONCLUSIONS: Transdermal buprenorphine appears to be an effective and well-tolerated analgesic option for pediatric palliative care patients with low opioid needs. Its ease of use and favorable side effect profile support its potential clinical utility. Prospective studies are warranted to confirm safety and guide dosing strategies.
    Keywords:  Drug Administration, Transdermal; Neurological Impairment; Off-Label Use; Opioid Rotation; Pain Management; Palliative Care
    DOI:  https://doi.org/10.1016/j.jpainsymman.2026.10.005
  27. J Clin Microbiol. 2026 Oct 12. e0112526
      
    Keywords:  blood culture; incubation period; pediatrics
    DOI:  https://doi.org/10.1128/jcm.01125-26
  28. Health Expect. 2026 Oct;29(5): e70917
       BACKGROUND: Paediatric patient safety incidents remain a significant global concern, with parents often playing a crucial role in detecting and preventing harm. Despite international calls for family partnerships in healthcare, evidence on how to meaningfully engage parents as participants in improvement interventions or within their development is limited.
    OBJECTIVE: To summarise and describe healthcare interventions that engage parents to improve key paediatric patient safety issues (relating to medication, communication, diagnosis and assessment, documentation, and administrative processes) and to explore the nature of parental engagement within the studies, including as research participants within the interventions themselves and/or the design and conduct of the study.
    METHODS: In this scoping review five databases (Medline, EMBASE, CINAHL, Web of Science and Scopus) and grey literature were searched for studies published from 2000 to August 2025. Eligible studies (published in English) described interventions aimed at mitigating key patient safety issues and engaged parents within the intervention and/or the wider study design. Data were independently charted and synthesised narratively using the Patient and Family Engagement (PFE) framework and the International Association for Public Participation (IAP2) Spectrum.
    RESULTS: 111 studies were included, predominantly from secondary care settings (n = 89, 80%), conducting experimental study designs (n = 43, 39%) or quality improvement projects (n = 36, 32%). Communication and medication safety were the most frequently targeted areas (n = 72, 65% and n = 55, 50%, respectively). Interventions were categorised into 17 groups, totalling 179 interventions, most commonly involving process standardisation (n = 26/111, 23%) or parent-targeted education (n = 25/111, 23%). Outcome measures largely reported parent-specific factors, such as their perception (n = 38/111, 10%) or knowledge (n = 21/111, 19%), with minimal evaluation of real-world safety outcomes. Parental engagement within healthcare interventions was focused on Direct Care (n = 108, 97.3%) and most commonly occurred through consultation-based approaches (n = 78, 70.3%). Parental engagement within research activities was primarily classified as Inform (n = 66, 59.5%), suggesting limited involvement in research design, development, or delivery.
    CONCLUSION: Parental engagement is essential to improving paediatric patient safety, yet it remains limited, inconsistent, and often tokenistic. Greater partnership with parents is needed, both as contributors to research and as partners in the design and delivery of healthcare services and safety interventions. Embedding engagement within research and quality improvement, alongside standardised approaches to its evaluation and reporting, will be critical to achieving a more inclusive, human-centred approach in which parental perspectives meaningfully shape safer paediatric care.
    PATIENT AND PUBLIC CONTRIBUTION: The parent patient and public involvement and engagement (PPPIE) contributor for this study met with the principal investigator on several occasions to review the findings and shape the interpretation of the results. They contributed to reviewing and editing the manuscript to improve clarity and accessibility.
    DOI:  https://doi.org/10.1111/hex.70917
  29. J Pediatr Pharmacol Ther. 2026 Oct;31(5): 653-658
       OBJECTIVE: Intravenous (IV) ibuprofen has recently been approved for treating moderate acute pain and fever, but evidence in pediatric use remains limited. This study aimed to evaluate the short-term safety of IV ibuprofen in children treated in a pediatric emergency department (PED).
    METHODS: A prospective observational study was conducted including children aged 6 months to younger than 14 years who received IV ibuprofen between January 2021 and September 2023 in a PED of a tertiary hospital. IV ibuprofen was administered for moderate acute pain or fever when oral administration was not feasible due to vomiting or the need for fasting before a potential surgical intervention. Physicians documented patient history, previous analgesia, reasons for consultation and IV ibuprofen administration, vital signs, pain scores (0-10) before and 10 minutes after administration, and any adverse events (AEs).
    RESULTS: We included 287 patients, with a median age of 9 years (IQR, 6-11). No serious AEs occurred, and no hospital admissions were required due to IV ibuprofen. Mild AEs occurred in 15 patients (5.2%), most commonly transient pain or itching at the infusion site. One patient developed a mild skin rash leading to treatment discontinuation, with complete recovery. Pain scores showed a median reduction of 3 points (IQR, 2-4).
    CONCLUSIONS: Short-term use of IV ibuprofen in the PED was associated with an acceptable safety profile and clinically relevant pain reduction. However, further research is needed to confirm these findings and to evaluate safety with repeated dosing or longer duration of use.
    Keywords:  NSAID; analgesia; intravenous ibuprofen; pediatric emergencies
    DOI:  https://doi.org/10.5863/JPPT-25-00160